Normal
and a good, a very interesting quarterly, and 30c easily breached.Financial Highlights • December quarterly sales of $7.9m were up by 50.1% vs the corresponding December 2019 quarter, and increased 34.2% vs the preceding September 2020 quarter, • Biopolymer sales were up 71.1% from the September 2020 quarter and now represent over 73.3% of total sales, • Driven by record biopolymer sales, SECOS expects to report a maiden profit for the first half for FY21, • SECOS reported a net operating cash outflow of $1.4 million in December 2020 quarter after investing over $2.6 million in new working capital to support increasing sales volumes, • The Balance Sheet remains strong with $14.3 million in cash and no debt, • Capex investment continues with additional extrusion and bagging lines in China and Malaysia to support increased demand.
and a good, a very interesting quarterly, and 30c easily breached.
Financial Highlights
• December quarterly sales of $7.9m were up by 50.1% vs the corresponding December 2019 quarter, and increased 34.2% vs the preceding September 2020 quarter,
• Biopolymer sales were up 71.1% from the September 2020 quarter and now represent over 73.3% of total sales,
• Driven by record biopolymer sales, SECOS expects to report a maiden profit for the first half for FY21,
• SECOS reported a net operating cash outflow of $1.4 million in December 2020 quarter after investing over $2.6 million in new working capital to support increasing sales volumes,
• The Balance Sheet remains strong with $14.3 million in cash and no debt,
• Capex investment continues with additional extrusion and bagging lines in China and Malaysia to support increased demand.
Hello and welcome to Aussie Stock Forums!
To gain full access you must register. Registration is free and takes only a few seconds to complete.
Already a member? Log in here.
